GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (FRA:CWY0) » Definitions » Float Percentage Of Total Shares Outstanding

Clearmind Medicine (FRA:CWY0) Float Percentage Of Total Shares Outstanding : 98.44% (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Clearmind Medicine's float shares is 3.26 Mil. Clearmind Medicine's total shares outstanding is 3.31 Mil. Clearmind Medicine's float percentage of total shares outstanding is 98.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Clearmind Medicine's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Clearmind Medicine's Institutional Ownership is 4.45%.

Clearmind Medicine Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Clearmind Medicine's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=3.26/3.31
=98.44%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clearmind Medicine (FRA:CWY0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (FRA:CWY0) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
TSXV:MRVL TSX:IPCI XCNQ:GLOW XCNQ:BIOV XCNQ:NOVA XCNQ:NIRV XCNQ:BRAX TSXV:WAVE XCNQ:MBIO TSX:APLI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
CMND:USA CWY0:Germany CMND:Canada
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Website
https://www.clearmindmedicine.com
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (FRA:CWY0) Headlines

No Headlines